PRN: Global Epigenetics Market - Analysis, Technologies & Forecasts to 2021 - Increasing Use of Epigenetics as a Tool to Understand Development & Disease

23/ago/2017 18:45:10 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 6 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Epigenetics Market - Analysis, Technologies & Forecasts to 2021 - Increasing Use of Epigenetics as a Tool to Understand Development & Disease

 
[23-August-2017]
 

DUBLIN, August 23, 2017 /PRNewswire/ --

The "Global Epigenetics Market 2017-2021" report has been added to Research and Markets' offering.

Research and Markets Logo

The global epigenetics market is expected to grow at a CAGR of 13.22% during the period 2017-2021.

The report, Global Epigenetics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

One trend in the market is increasing demand for personalized medicine. The demand for personalized medicine is increasing and is expected to grow in future with a CAGR of more than 10%. The development of whole genome technology, companion diagnostics, and the growing number of retail clinics are some reasons for its growth.

According to the report, one driver in the market is increasing prevalence of cancer. Epigenetic mechanisms are essential for the normal development and maintenance of tissue-specific gene expression patterns in mammals. The disruption of epigenetic processes can lead to the malicious transformation of cells and altered gene function. Alteration in the heritable epigenetic marks can result in inappropriate activation or inhibition of various signaling pathways and lead to disease states such as cancer. Cancer is one of the major public health problems globally. It is one of the leading causes of death. It was estimated that in 2012, more th! an 2% new cancer cases occurred globally.

Key vendors

  • Abcam
  • Bio-Rad Laboratories
  • Merck
  • Thermo Fisher Scientific

Other prominent vendors

  • Active Motif
  • BellBrook Labs
  • BioVision
  • Cisbio.com
  • Diagenode
  • Others

Key Topics Covered:

Part 01:Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Landscape

Part 06: Market Segmentation By Product

Part 07: Geographical Segmentation

Part 08: Decision Framework

Part 09: Drivers And Challenges

Part 10: Market Trends

Part 11: Vendor Landscape

Part 12: Key Vendor Analysis

Part 13: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/wlt52b/global.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl